{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:39:01Z","timestamp":1783431541343,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.metabol.2015.12.014","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T12:23:06Z","timestamp":1452169386000},"page":"569-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Anti-TNF\u03b1 treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-872X","authenticated-orcid":false,"given":"Dimitrios","family":"Basoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Fragiadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Tentolouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kokkinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.12.014_bb0005","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4103\/2230-8210.98023","article-title":"Necrobiosis lipoidica diabeticorum: a case-based review of literature","volume":"16","author":"Kota","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.12.014_bb0010","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-4632.2008.03549.x","article-title":"Skin blood flow in necrobiosis lipoidica diabeticorum","volume":"47","author":"Ngo","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.metabol.2015.12.014_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.sder.2007.02.004","article-title":"Necrobiosis lipoidica","volume":"26","author":"Peyr\u00ed","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.metabol.2015.12.014_bb0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289205","article-title":"The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions","volume":"11","author":"Sfikakis","year":"2010","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.metabol.2015.12.014_bb0025","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/120347540300700503","article-title":"Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses","volume":"7","author":"Drosou","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.metabol.2015.12.014_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000068465","article-title":"Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica","volume":"206","author":"Kolde","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.metabol.2015.12.014_bb0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archdermatol.2009.6","article-title":"Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with infliximab: report of a case","volume":"145","author":"Hu","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.metabol.2015.12.014_bb0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2340\/00015555-1117","article-title":"Treatment of pre-ulcerative necrobiosis lipoidica with infliximab","volume":"91","author":"Conte","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.metabol.2015.12.014_bb0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000328403","article-title":"Intralesional infliximab in noninfectious cutaneous granulomas: three cases of necrobiosis lipoidica","volume":"222","author":"Barde","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.metabol.2015.12.014_bb0050","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-4632.2004.02120.x","article-title":"Generalized necrobiosis lipoidica treated with a combination of split-thickness autografting and immunomodulatory therapy","volume":"43","author":"Cummins","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.metabol.2015.12.014_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000314694","article-title":"Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature","volume":"221","author":"Su\u00e1rez-Amor","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.metabol.2015.12.014_bb0060","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jaad.2005.11.1042","article-title":"Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept","volume":"54","author":"Zeichner","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.metabol.2015.12.014_bb0065","doi-asserted-by":"crossref","first-page":"854738","DOI":"10.1155\/2012\/854738","article-title":"Ulcerative necrobiosis lipoidica: is there a place for anti-TNF\u03b1 treatment?","volume":"2012","author":"Guedes","year":"2012","journal-title":"Case Rep Med"},{"issue":"12","key":"10.1016\/j.metabol.2015.12.014_bb0070","first-page":"12","article-title":"Treatment of necrobiosis lipoidica with etanercept and adalimumab","volume":"15","author":"Zhang","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.metabol.2015.12.014_bb0075","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00105-013-2535-z","article-title":"Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab","volume":"64","author":"Leister","year":"2013","journal-title":"Hautarzt"},{"key":"10.1016\/j.metabol.2015.12.014_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/iwj.12206","article-title":"Squamous cell carcinoma arising in ulcerated necrobiosis lipoidica diabeticorum","volume":"12","author":"Uva","year":"2015","journal-title":"Int Wound J"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:10:53Z","timestamp":1758427853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049516000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0026049516000020"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.014","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF\u03b1 treatment for recalcitrant ulcerative necrobiosis lipoidica diabeticorum: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}